Therapeutic delay and reduced functional status six months after thrombolysis for acute myocardial infarction

American Journal of Cardiology

Volumn 94, Issue 4, 2004, Pages 415-420

  Avorn, Jerry ^a   Knight, Eric ^a   Ganz, David A ^a   Schneeweiss, Sebastian ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; LANOTEPLASE;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HEART FUNCTION; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SCORING SYSTEM; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; AGED; DISABILITY EVALUATION; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; LIKELIHOOD FUNCTIONS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT ADMISSION; PROSPECTIVE STUDIES; RISK; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; UNITED STATES;

EID: 4344685469     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.04.055     Document Type: Article

References (12)

1. Morrow D.A., Antman E., Charlesworth A., Cairns R., Murphy S.A., Lemos J.A., Giugliano R.P., McCabe C.H., Braunwald E. Thrombolysis In Myocardial Infarction trial risk score for ST-elevation myocardial infarction a convenient, bedside, clinical score for risk assessment at presentation. Circulation. 102:2000;2031-2037
2. In TIME-II Investigators. Intravenous NPA for the Treatment of Infarcting Myocardium Early (InTime-II). Eur Heart J 2000;21:2005-2013.
3. Hlatky M.A., Boineau R.E., Higginbotham M.B., Lee K.L., Mark D.B., Califf R.M., Cobb F.R., Pryor D.B. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol. 64:1989;651-654
4. Hlatky M.A., Rogers W.J., Johnstone I., Boothroyd D., Brooks M.M., Pitt B., Reeder G., Ryan T., Smith H., Whitlow P., et al. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. N Engl J Med. 336:1997;92-99
5. Mark D.B., Naylor C.D., Hlatky M.A., Califf R.M., Topol E.J., Granger C.B., Knight J.D., Nelson C.L., Lee K.L., Clapp-Channing N.E., et al. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med. 331:1994;1130-1135
6. Nelson C.L., Herndon J.E., Mark D.B., Pryor D.B., Califf R.M., Hlatky M.A. Relation of clinical and angiographic factors to functional capacity as measured by the Duke Activity Index. Am J Cardiol. 68:1991;973-975
7. Alonso J., Permanyer-Miralda G., Cascant P., Brontons C., Prieto L., Soler-Soler J. Measuring functional status of chronic coronary patients. Eur Heart J. 18:1997;414-419
8. Daniel W.W. Biostatistics. 5th Ed :1987;291-293 Wiley, New York
9. Hosmer D.W., Lemeshow S. Applied Logistic Regression. 1989;Wiley, New York
10. Goldstein H., Rasbash J. Improved approximations for multilevel models with binary response. J R Stat Soc A. 158:1996;175-177
11. Armstrong B.G., Sloan M. Ordinal regression models for epidemiologic data. Am J Epidemiol. 129:1989;191-204
12. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med. 337:1997;1118-1123